Platelet count and erythrocyte sedimentation rate are good predictors of Kawasaki disease: ROC analysis

Journal of Clinical Laboratory Analysis

Volumn 24, Issue 6, 2010, Pages 385-388

  Xiu Yu, Song ^a   Jia Yu, Huang ^a   Qiang, Hong ^a   Shu Hui, Dai ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

C reactive protein; Erythrocyte sedimentation rate; Kawasaki disease; Platelet count; T cell

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFANT; LABORATORY TEST; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREDICTOR VARIABLE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; BLOOD; CHILD; COMPARATIVE STUDY; EARLY DIAGNOSIS; PRESCHOOL CHILD; PROGNOSIS;

BLOOD SEDIMENTATION; CHILD; CHILD, PRESCHOOL; EARLY DIAGNOSIS; FEMALE; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLATELET COUNT; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 78649613317     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20414     Document Type: Article

References (16)

1. Kobayashi T, Inoue Y, Takeuchi K. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 2006;113:2606-2612.
2. Huang WC, Huang LM, Chang IS. Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics 2009;123:E401-E405.
3. Dominguez SR, Friedman K, Seewald R. Kawasaki disease in a pediatric intensive care unit: A case-control study. Pediatrics 2008;122:E786-E790.
4. Newburger JW, Takahashi M, Gerber MA. Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation 2004;110:2747-2771.
5. Taki M, Kobayashi M, Ohi C. Spontaneous platelet aggregation in Kawasaki disease using the particle counting method. Pediatr Int 2003;45:649-652.
6. Benseler SM, McCrindle BW, Silverman ED. Infections and Kawasaki disease: Implications for coronary artery outcome. Pediatrics 2005;116:e760-e766.
7. Nigrovic LE, Nigrovic PA, Harper MB. Extreme thrombocytosis predicts Kawasaki disease in infants. Clin Pediatr 2006;45:446-452.
8. Hsieh KS, Weng KP, Lin CC. Treatment of acute Kawasaki disease: Aspirin's role in the febrile stage revisited. Pediatrics 2004;114:e689-e693.
9. + T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease. Pediatrics 2003;111:E140-E147.
10. Mitani Y, Sawada H, Hayakawa H. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease. Circulation 2005;111:38-43.
11. Abe BJ, Kotzn BL, Meissner C. Characterization of T-cell repertoire changes in acute Kawasaki disease. J Exp Med 1993;177:791-796.
12. Newburger JW, Sleeper LA, McCrindle BW. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med 2007;356:663-675.
13. Wright H, Waddington C, Geddes J. Facial nerve palsy complicating Kawasaki disease. Pediatrics 2008;122:E783-E785.
14. Blake GJ, Ridker PM. Ovel clinical markers of vascular wall inflammation. Circ Res 2001;89:763-771.
15. Järvisalo MJ, Harmoinen A, Hakanen M. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 2002;22:1323-1328.
16. Li XH, Li XJ, Li H. Epidemiological survey of Kawasaki disease in Sichuan province of China. J Trop Pediatr 2008;54:133-136.